B
Bio-Rad Laboratories BIO
$366.36
−1.11%
Nov 13
1W
1M
3M
6M
1Y
3Y
5Y
Key indicators
Price
P/E 10
Cheap
Expensive
Sales
+1%
$2.59B over 12 months
Net margin
39%
Low
High
Volatility
36%
Calm
Choppy
Bars: against the 28 close companies.
Key indicators
When a figure has a bar, the marker places it among its peers, and the further right it sits, the more the figure beats the others. Green marks the best third, red the weakest and white anything in between. Some figures stay white wherever they sit, like price, pace or holding time, because neither side is better there.
Earnings release
The day the company publishes its quarterly accounts: revenue, profit, and often its outlook. The price sometimes moves sharply that day, in either direction. Over the long term, what matters is the trend of profits from one quarter to the next, not the reaction of the day.
Posts
No posts about BIO yet.
About Bio-Rad Laboratories, Inc.Class A
Bio-Rad makes tools and test kits for life science research and clinical diagnostics. Universities, hospitals, drug makers and clinical labs buy its instruments, chemicals and diagnostic tests, and repeat purchases of consumables bring in recurring revenue. It also holds a large stake in Sartorius AG, whose share price swings its reported profit.